| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.005 | 0.9 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | -0.0062 | 0.9 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0053 | 0.9 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.0057 | 0.9 |
| mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | -0.0058 | 0.9 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | 0.011 | 0.9 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | -0.0049 | 0.9 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.006 | 0.9 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | 0.0052 | 0.9 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | -0.0037 | 0.9 |